https://www.selleckchem.com/pr....oducts/abbv-cls-484.
Subphenotypes have been identified in patients with sepsis and ARDS and are associated with different outcomes and responses to therapies. Can unique subphenotypes be identified among critically ill patients with COVID-19? Using data from a multicenter cohort study that enrolled critically ill patients with COVID-19 from 67 hospitals across the United States, we randomly divided centers into discovery and replication cohorts. We used latent class analysis independently in each cohort to identify subphenotypes based on clinical and
Like
Comment
Share
